About AFT Pharmaceuticals
AFT Pharmaceuticals is a 100% privately owned pharmaceutical company operating in Australia and New Zealand with full development, regulatory and sales/marketing operations.
In addition to distributing agency lines, AFT owns a significant portfolio of IP (trademarks, patents) and product licenses. AFT markets patented, branded & generic drugs and is also involved in drug development.
1998 – started in NZ with first sales made
2000 – acquired shareholdings in 2 South African Pharmaceutical Companies and a wholesaler
2002 – acquired first AFT wholly owned products
2004 – started Australian company and exited South Africa Investment
2004 – started drug development work and filed first 2 global patents
2006 – JV drug development agreement with an EU based company
2008 – Secured a licensing deal for 3 AFT products in SE Asia. Dec08, first launches in Malaysia
2009 – Global licensing negotiations for key development project
2009 – Launch of world first combination analgesic - Maxigesic – into New Zealand
Group Sales for Mar 2011 year will be over $35 million.
Our objective is to build a significant Australasian Pharmaceutical company which is also involved in drug development.
